South Korea's cosmetics exports reached $11.4 billion last year, ranking second worldwide
Pharma and biotech firms also enter the market, expanding partnership and M&A opportunities

On the 13th, customers, most of them foreign nationals, choose cosmetics at a beauty store in Myeongdong, Seoul. Photo by Heo Younghan.

On the 13th, customers, most of them foreign nationals, choose cosmetics at a beauty store in Myeongdong, Seoul. Photo by Heo Younghan.

View original image

As K-beauty continues to grow, the related mergers and acquisitions (M&A) market is also expanding. The trend is extending beyond cosmetics brands to encompass the entire value chain, including ingredients and materials, manufacturing, packaging, and distribution. Analysts say that partnerships and M&A opportunities are also widening as pharmaceutical and biotech companies enter the market.


On November 4, Deloitte Korea published a report titled “The Growth of K-Beauty and New Opportunities.” According to the report, South Korea’s cosmetics exports reached $11.4 billion (approximately 15.3421 trillion won) last year, ranking second globally after France. Exports in the first half of this year also hit a record high of $7 billion, up 27.3% from the same period a year earlier.


The report identified the division of labor between indie brands and ODM (original development manufacturing) companies as a key driver of K-beauty’s growth. Brands focus on product planning and marketing, while ODM companies handle development and production. This structure has enabled brands to launch products quickly and enter overseas markets without their own production facilities. This, in turn, has increased demand for ingredients, materials, and packaging companies. As overseas expansion has gathered pace, distribution and sales channels have also taken on a greater role. As a result, the report found that K-beauty’s competitiveness is built across the entire value chain, including ingredients and materials, ODM and OEM, packaging, brands, and distribution and platforms.


These changes are also reflected in M&A and investment trends. Investment approaches are becoming more diverse, ranging from acquisitions of controlling stakes in K-beauty companies to minority investments in growing brands and distribution platforms. Companies are using external investment to secure production and distribution capabilities or strengthen their brand portfolios.


The report cited KKR’s acquisition of Samhwa, a cosmetics container and packaging company; the acquisition of Dongyang FT, a cosmetics ingredients specialist, by global chemicals and ingredients distributor IMCD; and global private equity firm CVC’s investment in Silicon2, a global distribution platform for K-beauty, as key examples.


The entry of pharmaceutical and biotech companies into the K-beauty market is also seen as a new growth opportunity. South Korea’s dermocosmetics market grew at an average annual rate of 15.7% from 2020 to 2025. The report said pharmaceutical and biotech companies can pursue acquisitions and partnerships involving dermocosmetics brands, as well as joint research and development, drawing on their research and development assets, functional ingredients, and medical credibility.

"K-Beauty M&A Expands Beyond Brands to Ingredients, Distribution and More" View original image

The report projected that the K-beauty industry will enter a phase in which companies’ performance diverges according to their individual competitiveness, rather than growing in tandem across the market. To prepare, K-beauty companies should strengthen their core capabilities across the value chain while expanding into adjacent sectors and overseas markets through external collaboration and strategic investment and M&A, the report said. It advised investors to select targets based not only on growth potential but also on profitability and business synergies, and to develop strategies for increasing corporate value through post-merger integration (PMI) and further acquisitions.



Han Hyungju, a managing director in the Financial Advisory division at Deloitte Anjin, said, “Going forward, it will be important to identify companies with differentiated technologies and stable sources of profit, define business synergies with acquisition targets, and turn those synergies into corporate value.”

"K-Beauty M&A Expands Beyond Brands to Ingredients, Distribution and More" View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing